Prosecution Insights
Last updated: October 04, 2026

BIOSAFE S.A.

Technology area: Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

BIOSAFE S.A. maintains a company patent portfolio in the Chemistry & Materials technology area. The portfolio currently has 2 pending office actions. These actions are distributed across 2 distinct examiners, showing a distributed approach to the current workload. This distribution suggests that the company is engaging with multiple points of contact within the patent office simultaneously.

The filings are situated within 2 distinct art units. CHEN, CHANGRU is the busiest examiner for the company, managing 1 busiest examiner pending office action. This represents half of the total 2 pending office actions currently active for the portfolio. For a practitioner, the presence of 2 distinct art units indicates that the underlying technology may span different classification areas, requiring a strategy that accounts for the specific practices of each unit. The involvement of 2 distinct examiners further suggests that prosecution outcomes will be determined by multiple individual perspectives.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CHEN, CHANGRU 1 48.1% +41.4%
ABEL, LENORA A 1 68.3% +34.5%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17433463 Closed Tissue Disaggregation and Cryopreservation ABEL, LENORA A 35d
17776572 BUNG FOR INSULATING A CONTAINER AND COOLING METHODS CHEN, CHANGRU —

Top Art Units

Art UnitApps
1796 1
1799 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17776572 BUNG FOR INSULATING A CONTAINER AND COOLING METHODS CHEN, CHANGRU 1796 §103 Non-Final OA — Pending May 12, 2022
17433463 Closed Tissue Disaggregation and Cryopreservation ABEL, LENORA A 1799 §103 Non-Final OA 35d Pending Aug 24, 2021

Managing BIOSAFE S.A.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month